Steady state BE study dosing [Design Issues]

posted by dshah  – India, 2024-01-22 11:09 (531 d 20:38 ago) – Posting: # 23837
Views: 3,812

Hi NK!

❝ Kindly clarify, whether 2nd and 3rd dose on day 5 need to be administered or not? and sampling should be continued for 24 hours?


So you are asking for protocol preparation consideration. The study is in healthy volunteers- so I believe that AUC0-t/AUC0-inf>=0.8 also needs to be followed, so consider sampling accordingly.

Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,680 registered users;
43 visitors (0 registered, 43 guests [including 13 identified bots]).
Forum time: 08:48 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5